Intuitive Surgical, Inc. $ISRG Shares Newly Bought by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, HoldingsChannel.com reports. The firm acquired 5,744 shares of the medical equipment provider’s stock, valued at approximately $2,368,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Beaumont Financial Advisors LLC increased its holdings in Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 23 shares during the last quarter. Hughes Financial Services LLC raised its position in Intuitive Surgical by 40.7% in the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 24 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co lifted its stake in Intuitive Surgical by 1.0% during the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. lifted its stake in Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after purchasing an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC lifted its stake in Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after purchasing an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the sale, the vice president directly owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,056 shares of company stock worth $17,585,864 over the last ninety days. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $450.04 on Wednesday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company has a market cap of $156.00 billion, a PE ratio of 51.63, a P/E/G ratio of 3.17 and a beta of 1.45. The business has a 50-day simple moving average of $413.15 and a 200-day simple moving average of $431.20.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the company earned $2.40 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Oppenheimer restated an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Raymond James Financial restated an “outperform” rating and set a $480.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, Stifel Nicolaus dropped their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.